Holen Sie sich die Stockscreener-App
289.46
2.59%
-8.01
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$297.47
Offen:
$299.99
24-Stunden-Volumen:
258.49K
Relative Volume:
0.40
Marktkapitalisierung:
$20.81B
Einnahmen:
$2.96B
Nettoeinkommen (Verlust:
$487.70M
KGV:
43.36
EPS:
6.6758
Netto-Cashflow:
$344.00M
1W Leistung:
+5.41%
1M Leistung:
+10.81%
6M Leistung:
+35.06%
1J Leistung:
-5.89%
1-Tages-Spanne:
$289.08
$301.00
1-Wochen-Bereich:
$274.43
$322.34
52-Wochen-Spanne:
$187.43
$348.90
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Vergleichen Sie WST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
289.46 | 21.40B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
548.05 | 193.74B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
186.34 | 53.26B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
260.38 | 37.87B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
76.05 | 37.61B | 10.03B | 1.07B | 1.39B | 2.1549 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-15 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
What to do if you’re stuck in West Pharmaceutical Services Inc.Trade Risk Report & Expert Approved Momentum Trade Ideas - newser.com
Stephens Adjusts Price Target on West Pharmaceutical Services to $350 From $335 - MarketScreener
Is West Pharmaceutical Services Inc. stock testing key support2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com
West Pharmaceutical stock rating reiterated at Outperform by Evercore ISI - Investing.com
Jefferies Adjusts Price Target on West Pharmaceutical Services to $365 From $335, Maintains Buy Rating - MarketScreener
West Pharmaceutical Services, Inc. Announces the Launch of its West Synchrony Prefillable Syringe System at CPHI Worldwide in Frankfurt, Germany - MarketScreener
How strong is West Pharmaceutical Services Inc. stock revenue growthPortfolio Risk Summary & Pattern Based Trade Signal System - newser.com
West Pharma (NYSE: WST) debuts Synchrony PFS for biologics, available Jan 2026 - Stock Titan
Why West Pharmaceutical Services Inc. stock could rally in 2025Quarterly Trade Report & Technical Entry and Exit Tips - newser.com
How sustainable is West Pharmaceutical Services Inc. stock dividend payout2025 Major Catalysts & Fast Entry and Exit Trade Plans - newser.com
Will West Pharmaceutical Services Inc. see short term momentumJuly 2025 Sector Moves & Daily Volume Surge Signals - newser.com
Can West Pharmaceutical Services Inc. stock surprise with quarterly results2025 Volatility Report & Smart Allocation Stock Tips - newser.com
Is West Pharmaceutical Services Inc. stock bottoming outMarket Activity Summary & Safe Entry Point Alerts - newser.com
West Pharmaceutical Services (WST) Is Up 9.9% After Raising 2025 Guidance and Beating Q3 Expectations - Yahoo Finance
West Pharmaceutical Services (WST): Evaluating Valuation After Recent Share Price Momentum - Yahoo Finance
West Pharmaceutical Services, Inc. Experiences Revision in Its Stock Evaluation Metrics - Markets Mojo
West Pharmaceutical Services (WST) Margin Compression Reinforces Valuation Concerns Despite High-Quality Earnings - Sahm
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.02%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):